Revenue segments as reported by the company.

Clearing and transaction fees

Market data and information services

Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Compensation and benefits  

Technology

Professional fees and outside services

Amortization of purchased intangibles

Depreciation and amortization

Licensing and other fee agreements

Other expenses

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CME Group

CME Group, Inc. operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals. It offers futures and options on futures trading across asset classes through the CME Globex platform, fixed income trading via BrokerTec and FX trading on the EBS platform. In addition, it also operates CME Clearing, a central counterparty clearing provider. The company was founded in 1898 and is headquartered in Chicago, IL.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CME Group achieves record-breaking 2022 performance amidst market challenges

CME Group's 2022 performance was exceptional, marked by record volumes, revenue growth, and successful transitions. The company's focus on innovation, strategic positioning in energy and cryptocurrency markets, and pricing adjustments have driven positive outcomes. Challenges in margins and market uncertainties require careful navigation.

CME Group posts record Q1 earnings, eyes growth in SOFR

CME Group delivered a strong performance in Q1 2023, achieving record revenue and profitability driven by growth in interest rate and options trading.
The company's strategic focus on risk management, shareholder value creation, and market competitiveness positions it well for future growth and revenue generation.
While facing challenges in a competitive market environment, CME Group has opportunities to capitalize on the demand for SOFR products and options trading.
Optimism surrounding the company's future growth potential, coupled with effective expense management and revenue diversification, underpin its resilience and strategic outlook.

CME Group excels in Q2 with record revenue and strategic focus

CME Group's Q2 earnings call showcased strong financial performance, driven by growth across asset classes and a focus on customer-centric strategies. The company's emphasis on innovation, regulatory compliance, and market leadership positions it well for future growth.

CME Group reports strong Q3 earnings, eyes growth amid challenges

CME Group's Q3 2023 earnings call highlighted robust financial performance, operational efficiency, and strategic positioning. Despite facing regulatory challenges and cost management concerns, the company remains confident in its offerings and growth prospects. Opportunities for expansion through innovation and capitalizing on market trends were key discussion points.

CME Group achieves record 2023 results amidst global uncertainties

CME Group's record-breaking performance in 2023 underscores its market leadership and financial strength, with revenue growth, margin expansion, and strong product demand driving positive results.
While facing challenges from global uncertainties and market dynamics, the company's strategic focus on innovation, risk management, and efficiency positions it well to capitalize on opportunities in evolving markets.
By introducing new products, expanding partnerships, and navigating changing market conditions adeptly, CME Group demonstrates resilience and adaptability, paving the way for continued growth and success in the financial industry.
Overall, CME Group's strategic initiatives, financial performance, and market positioning reflect a company poised for sustained success, leveraging opportunities and strengths to overcome challenges and drive future growth.

CME Group achieves record earnings in Q1 2024, eyes growth

CME Group delivered a strong performance in Q1 2024, setting records in revenue and earnings.
The company faces challenges in managing expenses amid growth initiatives and competitive dynamics.
However, CME's strengths in market leadership, network infrastructure, and regulatory alignment position it well for future opportunities.
By capitalizing on data services and revenue growth avenues, CME can continue its upward trajectory in the market.

CME Group achieves record Q3 performance amidst regulatory challenges

CME Group's Q3 performance was exceptional, marked by record volumes and financial metrics. Despite challenges in regulatory compliance and competition, the company is well-positioned for growth through strategic opportunities in interest rate products and retail expansion.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

CHICAGO , Nov. 20, 2023 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that it will launch options on €STR futures, beginning in Q1 2024. "With consistently strong volumes, open interest in our €STR futures has continued growing exponentially during 2023, now up to 29,000 contracts, with over 80% of market participants choosing CME Group as their home for European Short Term Rate futures trading," said Mark Rogerson, EMEA Head of Interest Rate Products, CME Group.

CME Group to Launch €STR Options in Q1 2024

Subscribers to Schaeffer's Weekend Trader options recommendation service received this CME commentary on Sunday night, along with a detailed options trade recommendation -- including complete entry and exit parameters.

Call Traders Should Consider this Finance Stock

Second-place award will increase to $1 million Sponsorship extension through 2025 will continue to include Race to the CME Globe and charity tie-in for St. Jude Children's Research Hospital NAPLES, Fla. , Nov. 15, 2023 /PRNewswire/ -- The Ladies Professional Golf Association (LPGA) and CME Group, the world's leading derivatives marketplace, today announced an extension of the CME Group Tour Championship and the season-long Race to the CME Globe through 2025.

CME Group and LPGA Announce Two-Year Extension of CME Group Tour Championship with Increased $11 Million Purse and Record $4 Million First-Place Prize

Here is how CME Group (CME) and Erste Group Bank AG (EBKDY) have performed compared to their sector so far this year.

Is CME Group (CME) Stock Outpacing Its Finance Peers This Year?

Coinbase

Interactive Brokers

Block

Visa

Five Crypto-centric stocks in focus are: COIN, SQ, V, CME, IBKR.

5 Crypto-Centric Stocks in Focus Following Fed's Rate Pause

Overall volume grew 11% over October 2022 Strongest October in company history for interest rate ADV Record equity index options volume  driven by E-mini S&P 500 contracts Continued growth across SOFR and U.S. Treasury complexes CHICAGO , Nov. 2, 2023 /PRNewswire/ -- CME Group , the world's leading derivatives marketplace, today reported its October 2023 market statistics, reaching an average daily volume (ADV) of 25.2 million contracts during the month, an increase of 11% over 2022 and the company's highest-ever October ADV on record. Market statistics are available in greater detail at https://cmegroupinc.gcs-web.com/monthly-volume.

CME Group Reports Highest-Ever October ADV of 25.2 Million Contracts

CHICAGO , Oct. 30, 2023 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced the expansion of its U.S. Treasury options suite with the launch of Monday expiries. In addition to the existing Wednesday and Friday expiries, Monday expiries can deliver more precise risk management around market-moving events.

CME Group Expands Suite of Short-Term Options on U.S. Treasury Futures

Apple

Accenture Plc

Automatic Data Processing

AGCO

Applied Materials

A. O. Smith

Cardinal Health

Cboe Global Markets

Coterra Energy

Microsoft

NIKE

Raymond James

RenaissanceRe Hlds

Raytheon Technologies

SAP SE

Steel Dynamics

Vistra Energy

Verizon

W. R. Berkley

We explain why selling cash-covered puts and covered calls are relatively safe choices for earning a high income. We will discuss how to formulate a sustainable and repeatable options income strategy. In this monthly series, we present how to go about selecting the right kind of stocks for options income. We present two lists of 10 stocks with multiple scenarios: Put options, call options, and deep-in-the-money call options.

Aim For High Income And Less Risk With Options (November 2023)

CME Group Inc  (NASDAQ:CME) stock is up 0.9% at $215.99 at last check, after the company announced third-quarter earnings that topped estimates, while revenue missed expectations.

CME Group Stock Looks Ready for More Highs

NVIDIA

Five crypto-related stocks to watch are: NVDA, CME, COIN, SQ, IBKR.

5 Crypto-Focused Stocks to Buy Despite Wall Street Turmoil

CME Group's (CME) third-quarter results reflect higher revenues on increased trading volume.

CME Group (CME) Q3 Earnings Beat Estimates, Revenues Rise Y/Y

CME Group Inc. (NASDAQ:CME ) Q3 2023 Earnings Conference Call October 25, 2023 8:30 AM ET Company Participants Adam Minick - Senior Director, IR Terrence Duffy - Chairman and CEO Lynne Fitzpatrick - CFO Tim McCourt - Senior Managing Director and Global Head, Equity & FX Products Derek Sammann - Senior Managing Director and Global Head, Commodities, Options & International Markets Julie Winkler - Chief Commercial Officer Suzanne Sprague - Senior Managing Director and Global Head Of Clearing and Post-Trade Services Conference Call Participants Dan Fannon - Jefferies Patrick Moley - Piper Sandler Alex Kramm - UBS Owen Lau - Oppenheimer Brian Bedell - Deutsche Bank Kyle Voigt - KBW Benjamin Budish - Barclays Chris Allen - Citi Ken Worthington - JPMorgan Alex Blostein - Goldman Sachs Michael Cyprys - Morgan Stanley Craig Siegenthaler - Bank of America Andrew Bond - Rosenblatt Securities Elias Abboud - Bank of America Operator Greetings, and welcome to the CME Group Third Quarter 2023 Earnings Call. During the presentation, all participants will be in a listen-only mode.

CME Group Inc. (CME) Q3 2023 Earnings Call Transcript

CME Group (NASDAQ:CME) shares moved higher after it reported a year-over-year increase in profits for the third quarter as investors turned to its products to hedge against market volatility. The company, which operates a global derivatives marketplace, posted adjusted earnings per share of $2.25, up from $1.98 in the year-ago quarter and ahead of estimates of $2.21.

CME Group 3Q earnings top expectations on higher trading volumes

The headline numbers for CME (CME) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Here's What Key Metrics Tell Us About CME (CME) Q3 Earnings

CME Group (CME) came out with quarterly earnings of $2.25 per share, beating the Zacks Consensus Estimate of $2.21 per share. This compares to earnings of $1.98 per share a year ago.

CME Group (CME) Beats Q3 Earnings and Revenue Estimates

CHICAGO , Oct. 25, 2023 /PRNewswire/ -- CME Group Inc. (NASDAQ: CME) today reported financial results for the third quarter of 2023. The company reported revenue of $1.3 billion and operating income of $820 million for the third quarter of 2023.

CME Group Inc. Reports Third-Quarter 2023 Financial Results

Fair Isaac

Finance stocks CME and FICO are near new highs. CME offers a trading platform for futures contracts while FICO offers financial software products.

Two Finance Stocks Linger Near New Highs Amid Market Meltdown

Bitcoin is rebounding which is helping stocks like NVIDIA Corporation (NVDA), Coinbase Global, Inc. (COIN), Block Inc. (SQ) and CME Group Inc. (CME).

4 Stocks to Watch as Bitcoin Makes a Solid Rebound

CME Group's (CME) Q3 earnings are likely to have been aided by improved clearing, transaction fees and other revenues, and market data and information services. However, higher expenses might have been an offset.

Is a Beat in Store for CME Group (CME) This Earnings Season?

Does CME Group (CME) have what it takes to be a top stock pick for momentum investors? Let's find out.

Are You Looking for a Top Momentum Pick? Why CME Group (CME) is a Great Choice

Intercontinental Exchange

Nasdaq

Product innovation, increased market volatility and a strategic economic market model are expected to aid Securities and Exchanges stocks like CME, ICE, CBOE, NDAQ and COIN. However, compliance with regulations remains a challenge.

5 Securities and Exchanges to Gain From Increased Trading

5 Stocks in Focus in a consolidating crypto market are: NVDA, COIN, CME, SQ, IBKR.

5 Stocks in Focus Amid a Consolidating Crypto Market

Bitcoin is trying to stage another comeback, helping stocks like NVIDIA Corporation (NVDA), CME Group Inc. (CME) and Coinbase Global, Inc. (COIN).

3 Crypto Stocks to Buy as Bitcoin Attempts Another Rebound

Norfolk Southern

I discuss two stocks that offer high income, resilience during recessions, capital appreciation, and a high barrier to market entry. Norfolk Southern is a wide-moat railroad giant with a history of dividend growth, offering attractive buying opportunities despite recent headwinds. CME Group, a financial derivatives powerhouse, offers consistent income through dividends and special dividends and is well-positioned to benefit from rising rates and market volatility.

2 REIT-Like Dividend Stocks We're Buying With Both Hands

Bank of America

JPMorgan Chase & Co

To combat rising inflation, the U.S. Federal Reserve has raised the Federal Funds Rate from a range of 0% to 0.25% in March 2022 to a range of 5.25% to 5.5% at the time of writing. Now, since this key rate has reached its highest level since 2001, it has consumers wondering have interest rates peaked?

News for CME Group Stock (CME)